Applied Imaging receives 510(k) clearance:
This article was originally published in Clinica
Applied Imaging has received 510(k) approval for its Winscan automated imaging system for detecting foetal nucleated red blood cells. The device automatically scans slides from peripheral blood samples and stores colour images of the nucleated red blood cells in the sample. The company intends to integrate the Winscan in a non-invasive system of detecting foetal nucleated red blood cells from the mother's peripheral blood for chromosomal abnormalities.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.